Latest News and Press Releases
Want to stay updated on the latest news?
-
WASHINGTON, May 07, 2025 (GLOBE NEWSWIRE) -- OncLive®, the nation’s leading multimedia resource for oncology professionals and Pfizer (platinum supporter), DSI (platinum supporter) and Regeneron...
-
CRANBURY, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- OncLive invites physicians and oncology professionals to attend the 13th Annual Giants of Cancer Care® Awards Ceremony, an evening dedicated to...
-
CRANBURY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- OncLive®, the leading resource for oncology professionals, today formally announced the beta release of Scout, an artificial intelligence-powered...
-
CRANBURY, N.J., Oct. 09, 2024 (GLOBE NEWSWIRE) -- OncLive, the nation’s leading multimedia resource for oncology professionals, and the Ruesch Center for the Cure of Gastrointestinal (GI) Cancers at...
-
CRANBURY, N.J., May 22, 2024 (GLOBE NEWSWIRE) -- OncLive®, the nation’s leading multimedia resource for oncology professionals, is thrilled to announce an exciting collaboration with MedNews Week. ...
-
CRANBURY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- OncLive®, the nation’s leading multimedia resource for oncology professionals and Pfizer (platinum supporter), Exelixis (gold supporter) and...
-
CRANBURY, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- OncLive, the nation’s leading multimedia resource for oncology professionals, and The Ruesch Center for the Cure of Gastrointestinal (GI) Cancers,...
-
CRANBURY, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- OncLive®, the nation’s leading multimedia resource for oncology professionals and Pfizer (platinum sponsor) and Exelixis and Stemline (gold...
-
CRANBURY, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) -- OncLive®, the nation’s leading multimedia resource for oncology professionals, and The Ruesch Center for the Cure of Gastrointestinal (GI) Cancers,...
-
CRANBURY, N.J., May 09, 2022 (GLOBE NEWSWIRE) -- OncLive®, the nation’s leading multimedia resource for oncology professionals, along with our platinum (Pfizer) and gold (Gilead, Sanofi and...